» Articles » PMID: 35740188

Bacterial Resistance to Antibiotics and Clonal Spread in COVID-19-Positive Patients on a Tertiary Hospital Intensive Care Unit, Czech Republic

Abstract

This observational retrospective study aimed to analyze whether/how the spectrum of bacterial pathogens and their resistance to antibiotics changed during the worst part of the COVID-19 pandemic (1 November 2020 to 30 April 2021) among intensive care patients in University Hospital Olomouc, Czech Republic, as compared with the pre-pandemic period (1 November 2018 to 30 April 2019). A total of 789 clinically important bacterial isolates from 189 patients were cultured during the pre-COVID-19 period. The most frequent etiologic agents causing nosocomial infections were strains of Klebsiella pneumoniae (17%), Pseudomonas aeruginosa (11%), Escherichia coli (10%), coagulase-negative staphylococci (9%), Burkholderia multivorans (8%), Enterococcus faecium (6%), Enterococcus faecalis (5%), Proteus mirabilis (5%) and Staphylococcus aureus (5%). Over the comparable COVID-19 period, a total of 1500 bacterial isolates from 372 SARS-CoV-2-positive patients were assessed. While the percentage of etiological agents causing nosocomial infections increased in Enterococcus faecium (from 6% to 19%, p < 0.0001), Klebsiella variicola (from 1% to 6%, p = 0.0004) and Serratia marcescens (from 1% to 8%, p < 0.0001), there were significant decreases in Escherichia coli (from 10% to 3%, p < 0.0001), Proteus mirabilis (from 5% to 2%, p = 0.004) and Staphylococcus aureus (from 5% to 2%, p = 0.004). The study demonstrated that the changes in bacterial resistance to antibiotics are ambiguous. An increase in the frequency of ESBL-positive strains of some species (Serratia marcescens and Enterobacter cloacae) was confirmed; on the other hand, resistance decreased (Escherichia coli, Acinetobacter baumannii) or the proportion of resistant strains remained unchanged over both periods (Klebsiella pneumoniae, Enterococcus faecium). Changes in pathogen distribution and resistance were caused partly due to antibiotic selection pressure (cefotaxime consumption increased significantly in the COVID-19 period), but mainly due to clonal spread of identical bacterial isolates from patient to patient, which was confirmed by the pulse field gel electrophoresis methodology. In addition to the above shown results, the importance of infection prevention and control in healthcare facilities is discussed, not only for dealing with SARS-CoV-2 but also for limiting the spread of bacteria.

Citing Articles

Bacterial Infections, Trends, and Resistance Patterns in the Time of the COVID-19 Pandemic in Romania-A Systematic Review.

Vulcanescu D, Bagiu I, Avram C, Oprisoni L, Tanasescu S, Sorescu T Antibiotics (Basel). 2025; 13(12.

PMID: 39766609 PMC: 11726834. DOI: 10.3390/antibiotics13121219.


Bacterial Community- and Hospital-Acquired Pneumonia in Patients with Critical COVID-19-A Prospective Monocentric Cohort Study.

Doubravska L, Htoutou Sedlakova M, Fiserova K, Klementova O, Turek R, Langova K Antibiotics (Basel). 2024; 13(2).

PMID: 38391578 PMC: 10886267. DOI: 10.3390/antibiotics13020192.


Development and management of gastrointestinal symptoms in long-term COVID-19.

He K, Lei X, Zhang L, Wu D, Li J, Lu L Front Microbiol. 2023; 14:1278479.

PMID: 38156008 PMC: 10752947. DOI: 10.3389/fmicb.2023.1278479.


Bacterial coinfection and antibiotic resistance in hospitalized COVID-19 patients: a systematic review and meta-analysis.

Yusof R, Norhayati M, Mohd Azman Y PeerJ. 2023; 11:e15265.

PMID: 37128208 PMC: 10148641. DOI: 10.7717/peerj.15265.


A case report of fatal COVID-19 complicated by rapidly progressive sepsis caused by Klebsiella variicola.

Tanii R, Harada S, Saito H, Okamoto K, Doi Y, Suzuki M BMC Infect Dis. 2023; 23(1):184.

PMID: 36991335 PMC: 10052270. DOI: 10.1186/s12879-023-08128-9.

References
1.
Duran-Manuel E, Cruz-Cruz C, Ibanez-Cervantes G, Bravata-Alcantara J, Sosa-Hernandez O, Delgado-Balbuena L . Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19. J Infect Dev Ctries. 2021; 15(1):58-68. DOI: 10.3855/jidc.13545. View

2.
Alhazzani W, Moller M, Arabi Y, Loeb M, Gong M, Fan E . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020; 46(5):854-887. PMC: 7101866. DOI: 10.1007/s00134-020-06022-5. View

3.
Clancy C, Nguyen M . Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?. Clin Infect Dis. 2020; 71(10):2736-2743. PMC: 7197597. DOI: 10.1093/cid/ciaa524. View

4.
Quah J, Jiang B, Tan P, Siau C, Tan T . Impact of microbial Aetiology on mortality in severe community-acquired pneumonia. BMC Infect Dis. 2018; 18(1):451. PMC: 6122562. DOI: 10.1186/s12879-018-3366-4. View

5.
Lansbury L, Lim B, Baskaran V, Lim W . Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020; 81(2):266-275. PMC: 7255350. DOI: 10.1016/j.jinf.2020.05.046. View